ArticleArthritis research & therapy2018

Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.

Paola Di Benedetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.